BRIEF-AzurRx Bio Says Co Granted 180-Day Extension To June 1 To Regain Compliance With Listing Requirement

Reuters
07 Dec 2020

Dec 7 (Reuters) - AzurRx BioPharma Inc :

* AZURRX BIO- ON DEC 4, RECEIVED LETTER FROM NASDAQ, CO GRANTED 180-DAY EXTENSION TO JUNE 1, 2021 TO REGAIN COMPLIANCE WITH LISTING REQUIREMENT

Source text: () Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10